<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02897661</url>
  </required_header>
  <id_info>
    <org_study_id>NEU-CN-160814</org_study_id>
    <nct_id>NCT02897661</nct_id>
  </id_info>
  <brief_title>Washed Microbiota Transplantation Improves Nutritional Status of Patients With Crohn's Disease</brief_title>
  <official_title>Washed Microbiota Transplantation Combining Exclusive Enteral Nutrition Contribute to Nutritional Improvement of Patients With Crohns' Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Second Hospital of Nanjing Medical University</source>
  <brief_summary>
    <textblock>
      Patients with Crohns' disease (CD) are always complicated with malnutrition. Exclusive
      enteral nutrition (EEN) is an effective treatment to improve nutritional status and induce
      remission in patients with CD however a reduction in microbiota diversity was the most
      frequently reported effect of EEN. There was a raised critical question that whether EEN
      combining microbiota transplantation can bring much more benefits to those CD patients with
      malnutrition.

      Fecal microbiota transplantation (FMT) is an effective way of remodeling microbiota. The
      improved methodology of FMT in our group since 2014 was different from the traditional manual
      FMT and was recently coined as washed microbiota transplantation (WMT), which is dependent on
      the automatic facilities and washing process in a laboratory room with biosafety level 3.

      Importantly, the worse nutritional status might decrease the efficacy of FMT. Therefore,
      there was a raised critical question that when is the proper time to combine WMT for those CD
      patients requiring EEN. This trial aimed to explore the timing of WMT in CD patients with
      malnutrition and assess the efficacy and safety of the strategy using WMT combined with EEN
      in CD patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2016</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in hemoglobin</measure>
    <time_frame>Day 8 and day 15</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in albumin and prealbumin in g/L</measure>
    <time_frame>Day 8 and day 15</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in lymphocyte count in 10^9/L</measure>
    <time_frame>Day 8 and day 15</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of clinical remission</measure>
    <time_frame>day 15</time_frame>
    <description>HBI score ≤ 4</description>
  </secondary_outcome>
  <other_outcome>
    <measure>rate of adverse events</measure>
    <time_frame>in 1 month following WMT</time_frame>
    <description>abdominal pain, fever, increased frequency of defecation, etc.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Crohn's Diseases</condition>
  <arm_group>
    <arm_group_label>Early WMT and EEN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>WMT (day1), EEN (day1-15)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late WMT and EEN</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>WMT (day8), EEN (day1-15)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>WMT</intervention_name>
    <description>Washed microbiota transplantation (WMT) through mid-gut</description>
    <arm_group_label>Early WMT and EEN</arm_group_label>
    <arm_group_label>Late WMT and EEN</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>EEN</intervention_name>
    <description>Exclusive enteral nutrition (EEN) through feeding tube</description>
    <arm_group_label>Early WMT and EEN</arm_group_label>
    <arm_group_label>Late WMT and EEN</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. patients aged 18 to 65 years with active CD, as defined by Harvey-Bradshaw Index (HBI)
             score &gt;4;

          2. patients accompanied with malnutrition as assessed by Nutritional Risk Screening 2002
             (NRS2002) score ≥ 3 or Patient-Generated Subjective Global Assessment (PG-SGA) score ≥
             4;

          3. patients with high compliance.

        Exclusion Criteria:

          1. accompanying with contraindications of enteral nutrition (EN) such as ileus, active
             gastrointestinal bleeding and shock;

          2. severe comorbidities (e.g., Clostridium difficile infection, diabetes, cancer,
             cardiopulmonary failure and severe liver and kidney diseases;

          3. parenteral infection such as urinary infection, pneumonia, etc;

          4. steroids or biologicals use within 6 week;

          5. intestinal fibrotic stenosis;

          6. patients who are pregnant or going to be pregnant;

          7. patients with mental disorders.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faming Zhang, MD; PHD</last_name>
    <role>Study Chair</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Faming Zhang, MD; PHD</last_name>
    <phone>15005160838</phone>
    <email>fzhang@njmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Faming Zhang, MD, PhD</last_name>
      <phone>086-25-58509883</phone>
      <email>fzhang@njmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Tjellström B, Högberg L, Stenhammar L, Magnusson KE, Midtvedt T, Norin E, Sundqvist T. Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease. Scand J Gastroenterol. 2012 Dec;47(12):1454-9. doi: 10.3109/00365521.2012.703234. Epub 2012 Sep 28.</citation>
    <PMID>23016828</PMID>
  </reference>
  <reference>
    <citation>Cui B, Feng Q, Wang H, Wang M, Peng Z, Li P, Huang G, Liu Z, Wu P, Fan Z, Ji G, Wang X, Wu K, Fan D, Zhang F. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol. 2015 Jan;30(1):51-8. doi: 10.1111/jgh.12727.</citation>
    <PMID>25168749</PMID>
  </reference>
  <reference>
    <citation>Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, Li P, Chen Y, Yin H, Wang H, Marcella C, Cui B, Cheng L, Ji G, Zhang F. Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell. 2020 Apr;11(4):251-266. doi: 10.1007/s13238-019-00684-8. Epub 2020 Jan 9.</citation>
    <PMID>31919742</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>August 14, 2016</study_first_submitted>
  <study_first_submitted_qc>September 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2016</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Second Hospital of Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Faming Zhang</investigator_full_name>
    <investigator_title>Associate professor, Gastroenterology</investigator_title>
  </responsible_party>
  <keyword>fecal microbiota transplantation</keyword>
  <keyword>exclusive enteral nutrition</keyword>
  <keyword>washed microbiota transplantation</keyword>
  <keyword>malnutrition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

